Effects of the administration of a bovine non-specific immune stimulant around transportation on health and performance of Jersey and Jerseycross heifer calves in the first 60 days of life

Authors

  • B. O. Omontese Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108
  • M. L. Celestino Department of Veterinary Sciences, Texas Tech University, Lubbock, TX 79415
  • D. Paiva Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108
  • P. Menta Department of Veterinary Sciences, Texas Tech University, Lubbock, TX 79415
  • A. Garcia-Munoz Facultad de Veterinaria, Universidad CEU Cardenal Herrera, c/Tirant lo Blanc 7, 46115 Valencia, Spain
  • A. Masic NovaVive Inc., Napanee, ON, Canada
  • V. S. Machado Department of Veterinary Sciences, Texas Tech University, Lubbock, TX 79415
  • L. S. Caixeta Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108

DOI:

https://doi.org/10.21423/aabppro20197253

Keywords:

pre-weaned dairy calves, diarrhea, pneumonia, non-specific immune stimulant, transportation

Abstract

Health and performance of pre-weaned dairy calves have great influence on adult life performance. Amongst the diseases that affect young dairy calves, diarrhea and pneumonia are the most prevalent and economically important. The main objective of this study was to evaluate the effects of a non-specific immune stimulant (IS; Amplimune, NovaVive, Inc., Canada), administered around transportation, on the health and performance of Jersey and Jersey-cross heifer calves during the first 60 days of life. We hypothesized that calves receiving IS would have decreased disease treatment hazard, lower weekly health scores (HS), decreased mortality, and superior performance.

Downloads

Published

2019-09-12

Issue

Section

Research Summaries

Most read articles by the same author(s)

1 2 > >>